Mercator Medical Past Earnings Performance

Past criteria checks 0/6

Mercator Medical's earnings have been declining at an average annual rate of -32.6%, while the Medical Equipment industry saw earnings declining at 2.5% annually. Revenues have been declining at an average rate of 11.3% per year.

Key information

-32.6%

Earnings growth rate

-32.7%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate-11.3%
Return on equity-0.5%
Net Margin-0.5%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Mercator Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BST:MM2 Revenue, expenses and earnings (PLN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24489-21210
31 Mar 2448791230
31 Dec 23469-201270
30 Sep 23470-2321290
30 Jun 23491-1941410
31 Mar 23519-2141440
31 Dec 22543-1901450
30 Sep 22704201530
30 Jun 22926411490
31 Mar 221,3141671480
31 Dec 211,7294471480
30 Sep 212,1037891360
30 Jun 212,3341,1021330
31 Mar 212,1851,1951270
31 Dec 201,8359301170
30 Sep 201,3195831070
30 Jun 20872230950
31 Mar 2062123880
31 Dec 19540-2840
30 Sep 19534-1810
30 Jun 195010760
31 Mar 19452-1710
31 Dec 184208650
30 Sep 183649580
30 Jun 1833010520
31 Mar 1831610460
31 Dec 173015430
30 Sep 172925410
30 Jun 172848400
31 Mar 1727811400
31 Dec 1626414380
30 Sep 1625914370
30 Jun 1625411370
31 Mar 1623810350
31 Dec 1522710340
30 Sep 1521111310
30 Jun 1519312290
31 Mar 1518112270
31 Dec 1416810250
30 Sep 141608240
30 Jun 141547230
31 Mar 141516210

Quality Earnings: MM2 is currently unprofitable.

Growing Profit Margin: MM2 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MM2 is unprofitable, and losses have increased over the past 5 years at a rate of 32.6% per year.

Accelerating Growth: Unable to compare MM2's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MM2 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: MM2 has a negative Return on Equity (-0.53%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 11:59
End of Day Share Price 2024/10/15 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mercator Medical S.A. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tomasz RodakDom Maklerski Banku Ochrony Srodowiska S.A.
Dawid GórzynskiPKO BP Securities
Aleksandra JakubowskaVestor Dom Maklerski SA